The pharmacological treatment of attention-deficit hyperactivity disorder (ADHD) in adolescents is effective and relatively safe

被引:0
|
作者
不详
机构
关键词
Adolescents; Amfetamine; therapeutic use; Atomoxetine; Attention deficit hyperactivity disorder; treatment; Bupropion; Central nervous system stimulants; Clonidine;
D O I
10.2165/00042310-200723110-00003
中图分类号
学科分类号
摘要
Although the treatment of attention-deficit hyperactivity disorder in adolescents brings new challenges, stimulant and nonstimulant medications are likely to be as effective in adolescents as they are in younger children. To ensure coverage of school and extracurricular activities, the use of longer-acting formulations is often required. The risk of adverse effects appears to be outweighed by the benefits of treatmen. © 2007 Adis Data Information BV. All rights reserved.
引用
收藏
页码:9 / 12
页数:3
相关论文
共 50 条
  • [41] Efficacy of pharmacological therapies for attention deficit hyperactivity disorder (ADHD) treatment
    Casas, AM
    Soriano, JCP
    Miranda, MBR
    Delgado, FM
    PSICOTHEMA, 1996, 8 (01) : 89 - 105
  • [42] Hyperresponsiveness to social rewards in children and adolescents with attention-deficit/hyperactivity disorder (ADHD)
    Gregor Kohls
    Beate Herpertz-Dahlmann
    Kerstin Konrad
    Behavioral and Brain Functions, 5
  • [43] The efficacy, safety, and practicality of treatments for adolescents with attention-deficit/hyperactivity disorder (ADHD)
    Smith B.H.
    Waschbusch D.A.
    Willoughby M.T.
    Evans S.
    Clinical Child and Family Psychology Review, 2000, 3 (4) : 243 - 267
  • [44] Perceptions of ADHD Symptoms in Adolescents With Attention-Deficit/Hyperactivity Disorder: Attributions and Stigma
    Varma, Angela
    Wiener, Judith
    CANADIAN JOURNAL OF SCHOOL PSYCHOLOGY, 2020, 35 (04) : 252 - 265
  • [45] Hyperresponsiveness to social rewards in children and adolescents with attention-deficit/hyperactivity disorder (ADHD)
    Kohls, Gregor
    Herpertz-Dahlmann, Beate
    Konrad, Kerstin
    BEHAVIORAL AND BRAIN FUNCTIONS, 2009, 5
  • [46] Neurofeedback for the treatment of attention-deficit/hyperactivity disorder (ADHD) in childhood and adolescence
    Holtmann, M
    Stadler, C
    Leins, U
    Strehl, U
    Birbaumer, N
    Poustka, F
    ZEITSCHRIFT FUR KINDER-UND JUGENDPSYCHIATRIE UND PSYCHOTHERAPIE, 2004, 32 (03): : 187 - 200
  • [47] Lisdexamfetamine in the treatment of adolescents and children with attention-deficit/hyperactivity disorder
    Najib, Jadwiga
    ADOLESCENT HEALTH MEDICINE AND THERAPEUTICS, 2012, 3 : 51 - 66
  • [48] Diagnosis and treatment of children and adolescents with attention-deficit/hyperactivity disorder
    Brown, MB
    JOURNAL OF COUNSELING AND DEVELOPMENT, 2000, 78 (02): : 195 - 203
  • [49] A Review of the Pathophysiology, Etiology, and Treatment of Attention-Deficit Hyperactivity Disorder (ADHD)
    Sharma, Alok
    Couture, Justin
    ANNALS OF PHARMACOTHERAPY, 2014, 48 (02) : 209 - 225
  • [50] Venlafaxine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder
    Findling, Robert L.
    Greenhill, Laurence L.
    McNamara, Nora K.
    Demeter, Christine A.
    Kotler, Lisa A.
    O'Riordan, Mary Ann
    Myers, Carolyn
    Reed, Michael D.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2007, 17 (04) : 433 - 445